Lyphe Group Signs Term Sheet to Acquire Materia
· Combined entity will immediately encompass one of the largest medical cannabis footprints in Europe · Integrated product-to-patient supply chain includes manufacturing, import, and distribution already selling into key European markets · Company projecting pro forma revenues of £23MM in 2023 with gross margins in excess of 50%Lyphe Group, the UK’s largest medical cannabis company, has signed an agreement to acquire Materia, an EU GMP producer and distributor of medical cannabis across Europe (the “Transaction”). The combined entity (the “Company”) will bring together Lyphe